A recent study suggests that patients who come off popular GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass much more quickly than those who stop traditional diet and exercise programs.
Research printed in a prominent medical journal points out that while obese people frequently drop a large proportion of their body weight while using the jabs, the weight returns at an average rate of nearly a kilo each month after stopping.
"Users buying these drugs should be cognizant of the danger of quick weight regain when the medication concludes," stated lead investigator Dr. Susan Jebb.
This pace of recovery suggests a reversion to starting weight in about one and a half years.
Comparing Therapies
The analysis, which reviewed dozens of trials involving over 9,000 of patients, contrasted the results of GLP-1 agonists with conventional dieting.
Researchers note that people who shed pounds through lifestyle changes alone typically see a less rapid creep back—approximately 100 grams monthly—post-intervention.
Explaining the Quick Regain
Experts believe the way of the drugs is key to understanding the accelerated weight return.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Long-term administration of GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Stopping of this GLP-1 'fix' means hunger is uncontrolled, making binge eating much more probable."
A Chronic Disease?
The NHS suggest the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians say that, due to the high risk of relapse, the treatment should be considered long-term.
This opinion is supported by drug manufacturers, who say that the results "highlight the persistent character of obesity," similar to managing conditions like diabetes.
Patient Accounts
People who have discontinued the medication explain a powerful resurgence of cravings.
"It felt as if a switch activating and you're instantly starving," described a patient.
The struggle is compounded if individuals have not developed sustainable dietary or behavioural modifications during therapy.
Growing Interest
Figures suggest that a significant number of adults in the UK have tried these injections in the past year, with interest being substantial.
- Use is more common among females than males.
- The middle-aged age group shows the highest level of interest.
- A large proportion access the medications through private prescriptions rather than the NHS.
Finally, researchers stress that while the jabs are potent agents for shedding pounds, they are not a magic fix and lasting health benefits likely depends on ongoing lifestyle management.
